Clinical trial
TRANSCRANIAL MAGNETIC THERAPY (TMS) FOR TREATMENT OF PERINATAL DEPRESSION
NCT07928908 is registered in ClinicalTrials.gov with Rana Jawish as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- TRANSCRANIAL MAGNETIC THERAPY (TMS) FOR TREATMENT OF PERINATAL DEPRESSION
- Lead sponsor
- Rana Jawish
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 23, 2026
- Completion date
- May 31, 2029
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
perinatal depression
Arms
As registered; 1 arm.
-
Transcranial Magnetic Stimulation
All participants will receive active transcranial magnetic stimulation (TMS) targeting the left dorsolateral prefrontal cortex (DLPFC) using the NeuroStar TMS system. Treatment will consist of standard repetitive TMS (10 Hz) or intermittent theta burst stimulation (iTBS), delivered at 120% of the individual's resting motor threshold. Participants will receive one treatment session per day, up to five days per week, for a total of 20-36 sessions over approximately 4-8 weeks. Participants who achieve remission after completing at least 20 sessions may end treatment, while those who have not achieved remission may continue treatment for up to 36 sessions. All participants will be monitored for safety and clinical response throughout treatment.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Retention Rate
Proportion of participants who complete at least 20 TMS treatment sessions.
Similar trials
Same condition (Depression, Postpartum) and phase, most recent start first.
+379 more trials See the condition page